Approximately 90% of RTT patients have MECP2 mutations, a small portion carry mutations in other genes, such as CDKL5 and FOXG1, and can also result in phenotypes resembling RTT (Pejhan and Rastegar, 2021). The gene discussed is CDKL5; the disease is Rett syndrome.